Covered recipient · General Payments record
PRIYAL TEJASKUMAR AMIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2023–2025
$2,033.65
- Reported across 78 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,208.73 | 50 |
| Education | $175.00 | 2 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $195.01 | 3 |
| Celgene Corporation | $105.63 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $87.73 | 4 |
| Janssen Biotech, Inc. | $83.29 | 3 |
| Agios Pharmaceuticals, Inc. | $76.28 | 3 |
| SOBI, INC | $67.16 | 3 |
| ABBVIE INC. | $65.25 | 3 |
| Lilly USA, LLC | $63.27 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $59.62 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $59.17 | 2 |
| Regeneron Healthcare Solutions, Inc. | $55.44 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $55.27 | 2 |
| PUMA BIOTECHNOLOGY, INC. | $48.80 | 2 |
| Merck Sharp & Dohme Corporation | $47.19 | 2 |
| TAIHO ONCOLOGY, INC. | $30.28 | 1 |
| Karyopharm Therapeutics Inc. | $28.68 | 1 |
| Legend Biotech USA Inc. | $28.36 | 1 |
| Incyte Corporation | $28.30 | 1 |
| ARRAY BIOPHARMA INC | $23.24 | 1 |
| Novocure Inc. | $22.90 | 1 |
| PharmaEssentia USA Corporation | $22.00 | 1 |
| Daiichi Sankyo Inc. | $20.18 | 1 |
| Melinta Therapeutics, Inc. | $20.06 | 1 |
| Geron Corporation | $19.43 | 1 |
| PFIZER INC. | $19.27 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.92 | 1 |
| GlaxoSmithKline, LLC. | $17.10 | 1 |
| Genentech USA, Inc. | $16.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (52)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.